Tag: Parkinson’s Disease
-

New Survey Highlights Pill-Splitting Challenges in Parkinson’s Disease Treatment
Overview A recent study conducted by Avion Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, sheds light on a practical yet often overlooked issue in Parkinson’s disease management: pill-splitting. The survey explores how patients and caregivers cope with dividing medications, the impact on treatment adherence, and the potential consequences for health outcomes. By shining a light on…
-

Pill-Splitting Challenges in Parkinson’s Treatment: New Survey
New Survey Sheds Light on Pill-Splitting in Parkinson’s Disease Treatment A new survey released by Avion Pharmaceuticals, a subsidiary of Alora Pharmaceuticals, highlights a persistent challenge in Parkinson’s disease (PD) management: the need to split pills to manage dosage, timing, and side effects. The findings, drawn from responses of patients, caregivers, and clinicians, underscore how…
-

Darlington Grandad ‘Miraculously’ Survives Mountain Fall and Nine-Hour Rescue
Remarkable Survival After a Harsh Mountain Fall A Darlington-based grandfather, 74-year-old Keith Wilson, has spoken of his ‘miraculous’ survival after tumbling from a mountain height during an afternoon excursion. The nine-hour rescue mission, carried out by a dedicated team of volunteers and emergency responders, drew on every ounce of skill and endurance, ending with Keith…
-

Are Pesticides Making Farmers Sick? Parkinson’s Links Explained
Are pesticides making farmers sick? What the latest evidence says Pesticides protect crops and secure yields, but concerns persist about the health effects on those who handle them every day. In Switzerland, researchers are examining whether exposure to pesticides increases the risk of Parkinson’s disease among farmers. While Parkinson’s is recognized as an occupational disease…
-

Are Pesticides Making Farmers Sick? What We Know So Far
Introduction: A pressing question for farming communities The question of whether pesticides contribute to illness among farmers has moved from anecdote to a matter of public health attention. In Switzerland, researchers are examining whether exposure to pesticides might increase the risk of Parkinson’s disease among farmers. While Parkinson’s disease is recognized as an occupational concern…
-

Video-based machine learning models for predicting deep brain stimulation outcomes in Parkinson’s disease
Overview: Why video-based ML matters for DBS in Parkinson’s disease Deep brain stimulation (DBS) has transformed the management of advanced Parkinson’s disease, offering relief from tremor, rigidity, and bradykinesia for many patients. Yet outcomes vary, and selecting suitable candidates remains a nuanced, multidisciplinary task. Recent advances in video-based machine learning (ML) bring a new dimension…
-

Video-Based Machine Learning for Predicting DBS Outcomes in Parkinson’s Disease
Overview Deep brain stimulation (DBS) represents a transformative option for carefully selected Parkinson’s disease (PD) patients, offering relief from motor symptoms when medication alone is insufficient. Recent advances in video-based machine learning (ML) seek to forecast DBS outcomes more accurately, enabling clinicians to tailor interventions, set realistic expectations, and optimize patient selection. Building on foundational…
-

Video-Based Machine Learning Models Predicting Deep Brain Stimulation Outcomes in Parkinson’s Disease
Overview Deep brain stimulation (DBS) has transformed the treatment landscape for Parkinson’s disease (PD), offering symptom relief for many patients who do not respond adequately to medication. As DBS becomes more widely available, clinicians face the challenge of selecting the right candidates and predicting who will benefit most. Recent advances in video-based machine learning (ML)…
-

Brain Markers Could Offer Early Clues into Parkinson’s Disease
Unlocking Early Clues: Brain Markers in Parkinson’s Disease In the quest to understand Parkinson’s disease, researchers are turning to the brain’s own signaling system. A recent study leverages advanced brain imaging to explore how Parkinson’s disrupts the normal relationship between two key neural indicators. By identifying shifts in these markers, scientists hope to detect the…
-

Parkinson’s Brain Markers: Early Clues from Imaging
Parkinson’s Disease and the Search for Early Clues Parkinson’s disease affects millions, with more than 1.1 million people in the United States living with the condition. Researchers are racing to identify early signals that precede visible symptoms, aiming to diagnose sooner and tailor treatments that slow progression. A new study centers on brain imaging to…
